Related Experiment Video
Updated: May 11, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Anticoagulation in pregnant patients with mechanical heart valves: clinical considerations
Molly J Stout1, Anthony O Odibo
1Department of Obstetrics and Gynecology, Washington University in Saint Louis, St. Louis, MO 63110, USA. stoutm@wudosis.wustl.edu
Abstract:
Pregnancy management with mechanical heart valves is best done collaboratively with experienced cardiologists and maternal fetal medicine specialists. All anticoagulation options are associated with risks and benefits. Pregnancy is one situation in which the benefit of warfarin use may outweigh the risks. In light of the absence of definitive research to suggest a superior regimen, the risks, benefits, and limitations of each strategy should be discussed with the patient and specific attention given to her individual clinical situation.
Related Concept Videos
Mitral Valve Prolapse III: Nursing Management
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management